New approach to the diagnosis of growth hormone deficiency in adults
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Ghigo E, Aimaretti G, Gianotti L, Bellone J, Arvat E, Camanni F. New approach to the diagnosis of growth hormone deficiency in adults. Eur J Endocrinol 1996;134:352–6. ISSN 0804–4643 Pyridostigmine (PD), a muscarinic cholinergic agonist, and arginine (ARG) clearly increase the growth hormone (GH) response to growth hormone-releasing hormone (GHRH) in man. The current study was undertaken to investigate the value and safety of PD + GHRH and ARG + GHRH tests as well as the measurement of serum insulin-like growth factor I (IGF-I) in diagnosing GH deficiency in adults. Fifty-four patients considered GH deficient from extensive organic or idiopathic pituitary disease and 326 healthy adults were studied. The IGF-I concentrations were lower than the 3rd percentile of normal values in only 31 of the 54 (57.4%) patients with hypopituitarism. However, the IGF-I levels in hypopituitary patients and in normal subjects overlapped more frequently between 41 and 60 years (50%) and between 61 and 80 years (92.3%) as opposed to between 20 and 40 years (8.6%). In contrast to the IGF-I measurement, the ranges of peak GH responses to PD + GHRH and ARG + GHRH tests were clearly differentiated between the hypopituitary (0.2–6.8 and 0.1–9.5 μg/l, respectively) and normal subjects 17.7–114 and 16.1–119 μg/l, respectively). However, the PD + GHRH test was reliable only in subjects of 20–40 years of age. In conclusion, IGF-I measurement had no value in the diagnosis of GH deficiency in adults aged over 40 years, but is reliable enough when young adults of 20–40 years of age are considered. Both PD + GHRH and ARG + GHRH testing should be considered more reliable biochemical measurements of GH deficiency. In contrast to the PD + GHRH test, the ARG + GHRH test is reliable throughout the adult lifespan and appears to be the most appropriate for patient compliance and safety. F Camanni, Divisione di Endocrinologia, Ospedale Molinette, C.so Dogliotti 14, 10126 Torino, Italy
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545 · cited 1×
“On the other hand, the existence of an impaired function of the cholinergic nervous system in old people has been evidenced by others ( 25 , 26).”
Background
Cited by
Protein Therapeutics: A Summary and Pharmacological Classification
Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 2,161
Giustina, A., & Veldhuis, J. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0353 · Cited by 1,253
Serum levels of insulin-like growth factor I and its binding proteins in health and disease
Juul, A. (2003) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(03)00038-8 · Cited by 467
Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency
Biller, B. M. K., Samuels, M. H., Zagar, A., Cook, D. M., Arafah, B. M., Bonert, V., Stavrou, S., Kleinberg, D. L., Chipman, J. J., & Hartman, M. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8509 · Cited by 423
“Interestingly, two studies have reported higher peak GH levels to ARG-GHRH than to ITT, a finding not seen in our study (5, 15).”
BackgroundResultThe Diagnosis of Growth Hormone Deficiency in Children and Adults
Shalet, S. M., Toogood, A., Rahim, A., & Brennan, B. M. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.2.0329 · Cited by 414
Schneider, H. J., Aimaretti, G., Kreitschmann-Andermahr, I., Stalla, G.-K., & Ghigo, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60673-4 · Cited by 336
Self-citationCorneli, G., Di Somma, C., Baldelli, R., Rovere, S., Gasco, V., Croce, C. G., Grottoli, S., Maccario, M., Colao, A., Lombardi, G., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01967 · Cited by 317
Self-citationAimaretti, G., Corneli, G., Razzore, P., Bellone, S., Baffoni, C., Arvat, E., Camanni, F., & Ghigo, E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.5.4837 · Cited by 272
“5 mg/L, and our previous data showed that it reproducibly distinguishes between normal and GHD adult and elderly subjects (10, 23).”
InfluentialSelf-citationColao, A., Vitale, G., Cappabianca, P., Briganti, F., Ciccarelli, A., De Rosa, M., Zarrilli, S., & Lombardi, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030979 · Cited by 256
Prevalence of anterior pituitary insufficiency 3 and 12 months after traumatic brain injury
Schneider, H. J., Schneider, M., Saller, B., Petersenn, S., Uhr, M., Husemann, B., von Rosen, F., & Stalla, G. K. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02071 · Cited by 224
“This cutoff represents the first percentile in a lean population comparable to our study population, and is now generally accepted ( 23 , 24).”
MethodResultInfluentialPituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach
Tanriverdi, F., Schneider, H. J., Aimaretti, G., Masel, B. E., Casanueva, F. F., & Kelestimur, F. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1065 · Cited by 218
Self-citationColao, A., Di Somma, C., Pivonello, R., Loche, S., Aimaretti, G., Cerbone, G., Faggiano, A., Corneli, G., Ghigo, E., & Lombardi, G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5742 · Cited by 190
Self-citationTauber, M. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.352 · Cited by 208
“Another study (16) of 50 men (17 with isolated GH deficiency, 33 with multiple pituitary hormone deficiencies) 1.0 ‐15.5 yr after discontinuation of GH therapy for childhood-onset GHD found 100% persistent GHD (GH peak below 7 mg/L) using GHRH or the insulin tolerance test ( 24 ).”
MethodInfluentialPrevalence and predictive factors of post-traumatic hypopituitarism
Klose, M., Juul, A., Poulsgaard, L., Kosteljanetz, M., Brennum, J., & Feldt‐Rasmussen, U. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02860.x · Cited by 176
Pokrajac, A., Wark, G., Ellis, A. R., Wear, J., Wieringa, G. E., & Trainer, P. J. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02836.x · Cited by 172
Juul, A., Kastrup, K. W., Pedersen, S. A., & Skakkebæk, N. E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.4.3892 · Cited by 136
Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults
Gómez, J. M., Espadero, R. M., Escobar‐Jiménez, F., Hawkins, F., Picó, A., Herrera‐Pombo, J. L., Vilardell, E., Durán, A., Mesa, J., Faure, E., et al. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01472.x · Cited by 130
“…nocturnal sleep and exercise (Cain et al. , 1972; Lin & Tucci, 1974), short-term fasting (Aimaretti et al. , 1999), L -arginine (Fisker et al. , 1998), and recently, GHreleasing hormone and L -arginine (Ghigo et al. , 1996) or GHreleasing hormone and GH-releasing peptide-6 (Popovic et al. , 2000).”
BackgroundBonert, V. S., Elashoff, J. D., Barnett, P., & Melmed, S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032213 · Cited by 117
“In comparison with two prior studies aimed at establishing GH cut-off points for arginine-GHRH testing (14, 24), the assay used here was similar to that used by Maccario et al.”
MethodAging and the growth hormone/insulin like growth factor-I axis
Sherlock, M., & Toogood, A. A. (2007) · Pituitary · doi:10.1007/s11102-007-0039-5 · Cited by 124
“utilizing the combinations of GHRH and arginine and GHRH and GHRP6, two powerful stimuli of GH release that are not affected by age [79, 80].”
MethodHypopituitarism: Clinical Features, Diagnosis, and Management
Toogood, A. A., & Stewart, P. M. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.10.004 · Cited by 120
Elements in the pathophysiology of diminished growth hormone (GH) secretion in aging humans
Veldhuis, J. D., Iranmanesh, A., & WELTMAN, A. L. (1997) · Endocrine · doi:10.1007/bf02778061 · Cited by 104
Comparisons among old and new provocative tests of GH secretion in 178 normal adults
Aimaretti, G., Baffoni, C., DiVito, L., Bellone, S., Grottoli, S., Maccario, M., Arvat, E., Camanni, F., & Ghigo, E. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420347 · Cited by 104
Self-citationA simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency
Chihara, K., Shimatsu, A., Hizuka, N., Tanaka, T., Seino, Y., Katofor, Y., & _, _. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0066 · Cited by 98
“useful, reproducible, alternative test to the ITT ( 8 , 9) .I t is not affected by age but by gender and adiposity (9, 10).”
BackgroundColao, A. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.4.1277 · Cited by 102
“According to recent studies (10, 11 , 13) showing that adult patients with a GH peak after an ITT of less than 3 mg/L had a GH response to ARG1GHRH below 9 mg/L, whereas normal subjects had a GH response after ARG1GHRH always greater than 16.5 mg/L, we classified the GH response after ARG1GHRH in our 192 subjects as f…”
ResultInfluentialSelf-citationMaghnie, M., Aimaretti, G., Bellone, S., Bona, G., Bellone, J., Baldelli, R., de Sanctis, C., Gargantini, L., Gastaldi, R., Ghizzoni, L., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01873 · Cited by 101
Self-citationPaiva, E. S., Deodhar, A., Jones, K. D., & Bennett, R. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10209 · Cited by 98
Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults
Giustina, A., Barkan, A. L., Chanson, P., Grossman, A. B., Hoffman, A. R., Ghigo, E., Casanueva, F. F., Colao, A., Lamberts, S. W. J., Sheppard, M., et al. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03349263 · Cited by 100
Self-citationDiagnosis of adult GH deficiency
Ghigo, E., Aimaretti, G., & Corneli, G. (2007) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2007.07.004 · Cited by 103
Self-citationGiavoli, C., Libé, R., Corbetta, S., Ferrante, E., Lania, A., Arosio, M., Spada, A., & Beck-Peccoz, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1114 · Cited by 97
“[insulin tolerance test (ITT) or arginine GHRH] as previously reported (18).”
MethodRietveld, I., Janssen, J. A. M. J. L., Hofman, A., Pols, H., van Duijn, C. M., & Lamberts, S. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480171 · Cited by 96
“GH production and secretion decreases with increasing age (5, 8 ). In our study a genotype-specific pattern of age-related decrease in circulating IGF-I and IGFBP-3 levels was only observed in homozygous carriers of the 192 bp allele.”
BackgroundResultInfluentialGhigo, E., Aimaretti, G., Arvat, E., & Camanni, F. (2001) · Endocrine · doi:10.1385/endo:15:1:029 · Cited by 96
Self-citationCurrent concepts in the biochemical assessment of the patient with acromegaly
Freda, P. U. (2003) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(03)00029-7 · Cited by 93
“[48] E.”
BackgroundYuen, K. C. J., Johannsson, G., Ho, K. K. Y., Miller, B. S., Bergadá, I., & Rogol, A. D. (2023) · Endocrine Connections · doi:10.1530/ec-22-0504 · Cited by 97
Bex, M., Abs, R., Maiter, D., Beckers, A., Lamberigts, G., & Bouillon, R. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.1081 · Cited by 90
“The time of onset of GHD((40,41)) and the age of the patient((42,43)) are two factors determining baseline IGF-I, with significantly lower values in childhood-onset GHD and at a lower age ( 40 years), resulting in an increasing overlap between GHD patients and the normal range with age.”
BackgroundMethodInfluentialAimaretti, G., Baffoni, C., Bellone, S., Di Vito, L., Corneli, G., Arvat, E., Benso, L., Camanni, F., & Ghigo, E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6858 · Cited by 83
“Age-adjusted 3rd centile limits of normality for IGF-I levels in our lab (data derived from 336 NS, 20 ‐ 80 yr old) are: 108.5 mg/L between 20 ‐30 yr, 129.8 mg/L between 31‐ 40 yr, 72.3 mg/L between 41‐50 yr, 62.4 mg/L between 51‐ 60 yr, 41.5 mg/L between 61‐70 yr, and 24.7 mg/L between 71‐ 80 yr ( 16 ).”
BackgroundSelf-citationKlose, M., Watt, T., Brennum, J., & Feldt-Rasmussen, U. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0901 · Cited by 87
Saggese, G., Ranke, M., Saenger, P. H., Rosenfeld, R. G., Tanaka, T., Chaussain, J., & Savage, M. O. (1998) · Hormone Research in Paediatrics · doi:10.1159/000023298 · Cited by 95
“and the GHRH combined with arginine or pyridostigmine tests [”
BackgroundGarcia, J. M., Swerdloff, R., Wang, C., Kyle, M., Kipnes, M., Biller, B. M. K., Cook, D., Yuen, K. C. J., Bonert, V., Dobs, A., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1157 · Cited by 81
Glucagon stimulation test for the diagnosis of GH deficiency in adults
Conceição, F. L., Silva, A. D. C. E., Costa, A. J. L., & Vaisman, M. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345251 · Cited by 86
60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-GH axis: the past 60 years
Murray, P. G., Higham, C., & Clayton, P. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0120 · Cited by 86
Gender- and age-related differences in the endocrine parameters of acromegaly
Colao, A., Amato, G., Pedroncelli, A. M., Baldelli, R., Grottoli, S., Gasco, V., Petretta, M., Carella, C., Pagani, G. A., Tamburano, G., et al. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03345496 · Cited by 81
Veldhuis, J. D., Anderson, S. M., Shah, N., Bray, M., Vick, T. M., Gentili, A., Mulligan, T., Johnson, M. L., WELTMAN, A. L., Evans, W. S., et al. (2001) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(01)80005-8 · Cited by 79
Impaired Cardiac Performance in Elderly Patients with Growth Hormone Deficiency
Colao, A. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.11.3950 · Cited by 79
Klose, M., Stochholm, K., Janukonyté, J., Lehman Christensen, L., Frystyk, J., Andersen, M., Laurberg, P., Christiansen, J. S., & Feldt-Rasmussen, U. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2397 · Cited by 73
“Thus, differences in BMI and lack of 40- to 65-yearold controls in the study by Ghigo et al (29) may have discredited the PD-GHRH test.”
InfluentialThe Metabolic Profile in Active Acromegaly is Gender-Specific
Ciresi, A., Amato, M. C., Pivonello, R., Nazzari, E., Grasso, L. F. S., Minuto, F. M., Ferone, D., Colao, A., & Giordano, C. S. D. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2896 · Cited by 74
Pfeifer, M., Kanc, K., Verhovec, R., & Kocijančič, A. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01179.x · Cited by 71
“The various available tests for diagnosing GH deficiency in adults including the ITT have been the subject of recent re-evaluation (Hoffman et al., 1994; DeBoer et al., 1995; Ghigo et al., 1996; Shalet et al., 1998).”
BackgroundMethodThe metabolic effects of growth hormone in adipose tissue
Chaves, V. E., Júnior, F. M., & Bertolini, G. L. (2013) · Endocrine · doi:10.1007/s12020-013-9904-3 · Cited by 77
Toogood, A. A., Jones, J., O'Neill, P. A., Thorner, M. O., & Shalet, S. M. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00440.x · Cited by 75
Colao, A., Di Somma, C., Savastano, S., Rota, F., Savanelli, M. C., Aimaretti, G., & Lombardi, G. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1134 · Cited by 69
Self-citationWexler, T., Gunnell, L., Omer, Z., Kuhlthau, K., Beauregard, C., Graham, G., Utz, A. L., Biller, B., Nachtigall, L., Loeffler, J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2671 · Cited by 69
“Subjects were categorized as GH-sufficient based on peak GH levels above 9 ng/ml on a GHRH-arginine stimulation test (24, 25).”
MethodBarrea, L., Somma, C. D., Macchia, P. E., Falco, A., Savanelli, M. C., Orio, F., Colao, A., & Savastano, S. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.12.007 · Cited by 69
“[21] The GH response after ARG þ GHRH was classified as deficient (GHD) when the GH peak was 4.”
Aimaretti, G., Corneli, G., Baldelli, R., Di Somma, C., Gasco, V., Durante, C., Ausiello, L., Rovere, S., Grottoli, S., Tamburrano, G., et al. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01794.x · Cited by 67
“In fact, mean IGFI levels as well as IGFBP-3 and 24-h GH concentrations in GHD are lower than in normal adults but there is considerable overlap between the two groups (Hoffman et al., 1994; Bates et al., 1995; De Boer et al., 1995; Ghigo et al., 1996; Juul et al., 1997; Svensson et al., 1997; Aimaretti et al., 1998b,…”
BackgroundMethodResultInfluentialSelf-citationLucidi, P. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.2.353 · Cited by 67
Maghnie, M., Salati, B., Bianchi, S., Rallo, M., Tinelli, C., Autelli, M., Aimaretti, G., & Ghigo, E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7394 · Cited by 55
“The GHRH plus Arg test is one of the most powerful provocative tests of GH secretion (6, 11 , 12) and, differently from classical provocative tests, including ITT, shows good intraindividual reproducibility (12).”
BackgroundSelf-citationPartsch, C., Lämmer, C., Gillessen‐Kaesbach, G., & Pankau, R. (2000) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(00)80015-5 · Cited by 62
Amato, G. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.10.3720 · Cited by 62
Anterior Pituitary Hormone Abnormalities following Traumatic Brain Injury
Schneider, M., Schneider, H. J., & Stalla, G. K. (2005) · Journal of Neurotrauma · doi:10.1089/neu.2005.22.937 · Cited by 61
“Generally a cut-off point of 9 (cid:1) g/L is used (Ghigo et al., 1996; Aimaretti et al., 1998).”
Tanaka, T., Cohen, P., Clayton, P., Laron, Z., Hintz, R. L., & Sizonenko, P. C. (2002) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(02)00045-x · Cited by 60
Pituitary Physiology and Diagnostic Evaluation
Melmed, S. K., Kleinberg, D. L., & Ho, K. K. Y. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00008-0 · Cited by 64
Adult GH deficiency throughout lifetime
Thomas, J. D. J., & Monson, J. P. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0258 · Cited by 58
Usefulness of IGF-I assay for the diagnosis of GH deficiency in adults
Aimaretti, G., Corneli, G., Razzore, P., Bellone, S., Baffoni, C., BELLONE, J., Camanni, F., & Ghigo, E. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03347336 · Cited by 57
Self-citationNormal values of serum IGF-1 in adults: results from a Brazilian population
Rosario, P. W. (2010) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302010000500008 · Cited by 57
“5th percentiles of the values obtained for samples: (8-11,14,16);”
BackgroundMethodResultInfluentialTaskinen, M. H., Lipsanen‐Nyman, M., Tiitinen, A. E., Hovi, L., & Saarinen‐Pihkala, U. M. (2007) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3180f61b67 · Cited by 59
“Sex hormone binding globulin 31 (6-118) 79 (16-198) 0.”
InfluentialToogood, A. A. (2003) · Hormone Research in Paediatrics · doi:10.1159/000071234 · Cited by 58
Granada, M., Murillo, J., Lucas, A., Salinas, I., Llopis, M., Castells, I., Foz, M., & Sanmarti, A. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420243 · Cited by 52
GHRH Plus Arginine in the Diagnosis of Acquired GH Deficiency of Childhood-Onset
Maghnie, M. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.6.2740 · Cited by 50
Self-citationEndocrine dysfunction in patients operated on for non-pituitary intracranial tumors
Schneider, H. J., Rovere, S., Corneli, G., Croce, C. G., Gasco, V, Rudà, R., Grottoli, S., Stalla, G. K., Soffietti, R., Ghigo, E., et al. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02272 · Cited by 51
“infusion over 30 min from 0toC30 minatdoseof0.5 g/kg uptoamaximum of 30 g) test ( 13 , 14); GH assays were performed at C30,C45,C60, and C90 min.”
MethodSelf-citationNormal Values of Insulin-Like Growth Factor I and Their Clinical Utility in Adults
Strasburger, C. J., Bidlingmaier, M., Wu, Z., & Morrison, K. M. (2001) · Hormone Research in Paediatrics · doi:10.1159/000063484 · Cited by 50
“This has proved problematic for a number of reasons: firstly, IGF-I levels vary significantly throughout the adult population, and so to have meaning they must be correlated with another parameter, most probably age. Secondly, IGF-I levels can be affected by concomitant disease and, lastly, different study and assay m…”
Hoeck, H. C., Jakobsen, P. E., Vestergaard, P., Falhof, J., & Laurberg, P. (1999) · Growth Hormone & IGF Research · doi:10.1054/ghir.1998.0085 · Cited by 49
Koutkia, P., Hron, B. M., Breu, J. J., & Grinspoon, S. K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1342 · Cited by 49
Giavoli, C., Cappiello, V., Corbetta, S., Ronchi, C. L., Morpurgo, P. S., Ferrante, E., Beck-Peccoz, P., & Spada, A. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02067.x · Cited by 50
Biochemical investigations in diagnosis and follow up of acromegaly
Schilbach, K., Strasburger, C. J., & Bidlingmaier, M. (2017) · Pituitary · doi:10.1007/s11102-017-0792-z · Cited by 50
Giavoli, C., Porretti, S., Ronchi, C. L., Cappiello, V., Ferrante, E., Orsi, E., Arosio, M., & Beck-Peccoz, P. (2004) · Metabolism · doi:10.1016/j.metabol.2003.11.025 · Cited by 48
Impairment of GH secretion in adults with primary empty sella
Gasperi, M., Aimaretti, G., Cecconi, E., Colao, A., Somma, C. D., Cannavò, S., Baffoni, C., Cosottini, M., Curtò, L., Trimarchi, F., et al. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03344013 · Cited by 44
Self-citation6 Ageing and growth hormone status
Toogood, A. A., & Shalet, S. M. (1998) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(98)80023-2 · Cited by 49
Scacchi, M., Danesi, L., Cattaneo, A., Valassi, E., Giraldi, F. P., Argento, C., D’Angelo, E., Mirra, N., Carnelli, V., Zanaboni, L., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03191.x · Cited by 43
Ghigo, E., Aimaretti, G., Maccario, M., Fanciulli, G., Arvat, E., Minuto, F. M., Giordano, G. D., Delitala, G., & Camanni, F. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.6.e1009 · Cited by 43
Self-citationPitfalls in the Biochemical Assessment of Acromegaly
Freda, P. U. (2003) · Pituitary · doi:10.1023/b:pitu.0000011174.79946.10 · Cited by 42
“Despite this gender difference in the relationship between GH and IGF-I, some studies do not report a gender specific normal IGF-I ranges in adults [44,46] whereas others have found IGF-I levels to be lower [48] or higher [49] in men than women throughout all or some [45] adult age ranges.”
BackgroundAn audit of the insulin-tolerance test in 255 patients with pituitary disease
Lange, M., Svendsen, O. L., Skakkebæk, N. E., Müller, J., Juul, A., Schmiegelow, M., & Feldt‐Rasmussen, U. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470041 · Cited by 42
Bülow, B., & Erfurth, E. M. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00595.x · Cited by 43
Ghigo, E., Arvat, E., Aimaretti, G., Broglio, F., Giordano, R., & Camanni, F. (1998) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(98)80027-x · Cited by 45
Self-citationHoeck, H. C., Vestergaard, P., Jakobsen, P. E., Falhof, J., & Laurberg, P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6538 · Cited by 37
“A cut-off limit of 3 mg/L has been suggested for the ITT (7, 30), and a recent study observed no differences in the stimulated GH response in pituitary patients during the ITT and PD1GHRH test (13).”
BackgroundResultInfluentialDiagnosing Growth Hormone Deficiency in Adults
Glynn, N., & Agha, A. (2012) · International Journal of Endocrinology · doi:10.1155/2012/972617 · Cited by 44
Gasperi, M., Aimaretti, G., Scarcello, G., Corneli, G., Cosci, C., Arvat, E., Martino, E., & Ghigo, E. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5904 · Cited by 40
“Testing with GHRH alone has no diagnostic value (18), but when GHRH is given in combination with arginine (ARG) it becomes one of the most useful, reproducible, and age-independent provocative tests to evaluate the maximal secretary capacity of somatotrope cells ( 4 , 18, 19).”
BackgroundMethodResultSelf-citationPituitary Physiology and Diagnostic Evaluation
Kaiser, U. B., & Ho, K. K. Y. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00008-3 · Cited by 49
Growth hormone deficiency (GHD) in adult thalassaemic patients
Scacchi, M., Danesi, L., Cattaneo, A., Valassi, E., Giraldi, F. P., Argento, C., D’Angelo, E., Mirra, N., Carnelli, V., Zanaboni, L., et al. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02965.x · Cited by 39
Current diagnosis of acromegaly
Cordero, R. A., & Barkan, A. L. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9060-2 · Cited by 47
Javed, Z., Qamar, U., & Sathyapalan, T. (2015) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.167561 · Cited by 43
Growth hormone status in morbidly obese subjects and correlation with body composition
Savastano, S., Somma, C. D., Belfiore, A., Guida, B., Orio, F., Rota, F., Savanelli, M. C., Cascella, T., Mentone, A., Angrisani, L., et al. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344144 · Cited by 42
“A GH response of 9 μg/l or less with a GHRH+ARG test was diagnostic for severe GHD (14).”
BackgroundMethodInfluentialBjörk, J., Link, K., & Erfurth, E. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0304 · Cited by 37
Profka, E., Giavoli, C., Bergamaschi, S., Ferrante, E., Malchiodi, E., Sala, E., Verrua, E., Rodari, G., Filopanti, M., Beck‐Peccoz, P., et al. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0196-0 · Cited by 37
Savastano, S., Somma, C. D., Colao, A., Barrea, L., Orio, F., Finelli, C., Pasanisi, F., Contaldo, F., & Tarantino, G. (2014) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2014.10.006 · Cited by 35
“[21]: ARG (arginine hydrochloride, Salf, Bergamo, Italy) was administered at a dose of 0.”
MethodSomatotropic Axis and Obesity: Is There Any Role for the Mediterranean Diet?
Muscogiuri, G., Barrea, L., Laudisio, D., Di Somma, C., Pugliese, G., Salzano, C., Colao, A., & Savastano, S. (2019) · Nutrients · doi:10.3390/nu11092228 · Cited by 33
Pitfalls of Insulin-Like Growth Factor I Assays
Bidlingmaier, M. (2009) · Hormone Research in Paediatrics · doi:10.1159/000178034 · Cited by 35
“Accurate interpretation of IGF-I values is contingent upon careful consideration of two issues: biological variability and discrepancies between different analytical methods. Effect of Biological Variability on IGF-I ConcentrationsAge is the main biological determinant of IGF-I levels. Concentrations are low at birth,…”
BackgroundPrevalence of GH deficiency in cured acromegalic patients: impact of different previous treatments
Ronchi, C. L., Giavoli, C., Ferrante, E., Verrua, E., Bergamaschi, S., Ferrari, D. I., Corbetta, S., Montefusco, L., Arosio, M., Ambrosi, B., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0222 · Cited by 34
Savastano, S., Di Somma, C., Angrisani, L., Orio, F., Longobardi, S., Lombardi, G., & Colao, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1476 · Cited by 34
Carmichael, J. D., Danoff, A., Milani, D., Roubenoff, R., Lesser, M. L., Livote, E., Reitz, R. E., Ferris, S., & Kleinberg, D. L. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02569.x · Cited by 35
Ranke, M. B., Osterziel, K. J., Schweizer, R., Schüett, B. S., Weber, K., Röbbel, P., Vornwald, A., Blumenstock, G., & Elmlinger, M. W. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.203 · Cited by 37
Low IGF-I levels are often uncoupled with elevated GH levels in catabolic conditions
Gianotti, L., Broglio, F., Aimaretti, G., Arvat, E., Colombo, S. F., Summa, M. D., Gallioli, G., Pittoni, G., Sardo, E., Stella, M., et al. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350325 · Cited by 34
Self-citationHam, J. N., Ginsberg, J. P., Hendell, C. D., & Moshang, T. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02272.x · Cited by 33
Metadata
- Authors
- Ghigo, E., Aimaretti, G., Gianotti, L., Bellone, J., Arvat, E., & Camanni, F.
- Affiliations
- University of Turin (IT)
- Corresponding author
- Camanni, Franco
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-03
- Volume
- 134
- Issue
- 3
- Pages
- 352-356
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W1983364664
- Cited by
- 257
- References
- 1
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 3 · 2017: 7 · 2016: 3 · 2015: 11 · 2014: 4 · 2013: 11 · 2012: 9
- FWCI
- 13.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- growth hormone deficiency, adults, pyridostigmine, L-arginine, insulin-like growth factor I, hypopituitarism, pituitary disorders, test safety
- MeSH terms
- Adult, Aged, Aged, 80 and over, Arginine, Female, Humans, Hypopituitarism, Insulin-Like Growth Factor I, Male, Middle Aged, Pyridostigmine Bromide, Growth Hormone, Growth Hormone-Releasing Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.